matti lehtinen

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Biology Cancer Biology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Karolina Louvanto

University of Tampere

FINLAND

View details

Maria Hortlund

Karolinska Institutet

SWEDEN

View details

Martin Widschwendter

University of Innsbruck

AUSTRIA

View details

Ville Nikolai Pimenoff

Karolinska Institutet

SWEDEN

View details

Sara Nordqvist Kleppe

Karolinska Institutet

SWEDEN

View details

Johannes Bogaards

A/Prof

Amsterdam UMC

NETHERLANDS

View details

Claudia Robles

Institut Català d'Oncologia

SPAIN

View details

belinda nedjai

Associate Professor/ Reader in Cancer Biomarkers and Epigenetics molecular epidemiology

Queen Mary University of London

UNITED KINGDOM

View details

Eduardo L. Franco

McGill University

CANADA

View details

Nicolas Folschweiller

Head Clinical Development Leads Vaccines

Biogen (Switzerland)

SWITZERLAND

View details

Joakim Dillner

Professor

Karolinska Institutet

SWEDEN

View details

Jorma Paavonen

University of Helsinki

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

matti lehtinen

Research Interests

Explore related searches

Contact this professor

Articles (18)

Elevated Risk of HPV‐Associated Oropharyngeal Cancers in Husbands of Women With Anogenital Cancer

Scientific approaches to defining HPV vaccine‐induced protective immunity

Elimination of cervical cancer by refined vaccination and screening

Scientific approaches toward improving cervical cancer elimination strategies

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era

HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study.

Human papillomavirus genotype replacement: Cstill too early to tell?

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs

Elimination of HPV-associated oropharyngeal cancers in Nordic countries

Preterm birth rate after bivalent HPV vaccination: Registry-based follow-up of a randomized clinical trial

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers

Effectiveness of various human papillomavirus vaccination strategies

Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries

Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project

Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women

Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank

Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial

Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials

Collaborators (12)

Karolina Louvanto

Maria Hortlund

Martin Widschwendter

Ville Nikolai Pimenoff

Sara Nordqvist Kleppe

Johannes Bogaards

Claudia Robles

belinda nedjai

Eduardo L. Franco

Nicolas Folschweiller

Joakim Dillner

Jorma Paavonen

Make your next move.